HemoGenyx Pharmaceuticals (LON:HEMO)

HemoGenyx Pharmaceuticals (LON:HEMO)


Share Price
3.05 p
Change
-0.05 (-1.61 %)
Market Cap
£11.02 m
Proactive Investors - Run By Investors For Investors

HemoGenyx Pharmaceuticals

HemoGenyx Pharmaceuticals PLC. is a publicly traded company (LSE: HEMO) headquartered in London, with its wholly owned US operating subsidiary, HemoGenyx LLC, located in Brooklyn, New York at its state- of- the- art research facility ("HemoGenyx").

For more than 50 years, bone marrow transplantation has been used to save the lives of patients suffering from blood diseases. The risk of...

EPIC: HEMO
Market: LSE:HEMO
52-week High/Low: 3.900p / 1.800p
Sector: Nonequity Investment Instruments
Market Cap: £11.02 m
Website: www.hemogenyx.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of HemoGenyx Pharmaceuticals


HemoGenyx Pharmaceuticals Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use